High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2467-2475

  Sämpi, Maritta ^a,b   Veneskoski, Marja ^b   Ukkola, Olavi ^a,b   Kesäniemi, Y Antero ^a,b   Hörkkö, Sohvi ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BACTERIAL POLYSACCHARIDE; BIOLOGICAL MARKER; CELL WALL POLYSACCHARIDE; COPPER; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; INSULIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ADULT; AGE; ALCOHOL CONSUMPTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BODY MASS; CHEMOLUMINESCENCE; COHORT ANALYSIS; CONTROLLED STUDY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMPAIRED GLUCOSE METABOLISM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BINDING; RISK FACTOR; SEX; SMOKING; STREPTOCOCCUS; ADIPOSE TISSUE; BLOOD; BLOOD PRESSURE; HISTOLOGY; LIVER; METABOLIC SYNDROME X; METABOLISM; OBESITY; PATHOPHYSIOLOGY;

ADIPOSE TISSUE; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INSULIN; LIPOPROTEINS, LDL; LIVER; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY;

EID: 77952786900     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1858     Document Type: Article

References (40)

1. Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR 2008 Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299:2287-2293
2. Girona J, Manzanares JM, Marimón F, Cabré A, Heras M, Guardiola M, Ribalta J, Masana L 2008 Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutr Metab Cardiovasc Dis 18:380-387
3. Hörkkö S, Binder CJ, Shaw PX, Chang MK, Silverman G, Palinski W, Witztum JL 2000 Immunological responses to oxidized LDL. Free Radic Biol Med 28:1771-1779
4. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL 1992 Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339:883-887
5. Chou MY, Fogelstrand L, Hartvigsen K, Hansen LF, Woelkers D, Shaw PX, Choi J, Perkmann T, Bäckhed F, Miller YI, Hörkkö S, Corr M, Witztum JL, Binder CJ 2009 Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119:1335-1349
6. Karvonen J, Päivänsalo M, Kesäniemi YA, Hörkkö S 2003 Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation 108:2107-2112
7. Hulthe J, Bokemark L, Fagerberg B 2001 Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men. Arterioscler Thromb Vasc Biol 21:101-107 (Pubitemid 32063236)
8. Tsimikas S, Brilakis ES, Lennon RJ, Miller ER, Witztum JL, McConnell JP, Kornman KS, Berger PB 2007 Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res 48:425-433
9. Shaw PX, Hörkkö S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, Witztum JL 2000 Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105:1731-1740
10. Hörkkö S, Bird DA, Miller E, Itabe H, Leitinger N, Subbanagounder G, Berliner JA, Friedman P, Dennis EA, Curtiss LK, Palinski W, Witztum JL 1999 Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103:117-128
11. Binder CJ, Hörkkö S, Dewan A, Chang M, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman GJ 2003 Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9:736-743
12. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesäniemi YA 1999 Prevalence of the metabolic syndrome in drugtreated hypertensive patients and control subjects. J Intern Med 245:163-174 (Pubitemid 29089113)
13. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
14. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553
15. Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M 1983 Ultrasonographical diagnosis of fatty liver: significance of the liverkidney contrast. Tohoku J Exp Med 139:43-50 (Pubitemid 13164807)
16. Habeeb AF 1966 Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14:328-336
17. Sämpi M, Ukkola O, Päivänsalo M, Kesäniemi YA, Binder CJ, Hörkkö S 2008 Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis. J Am Coll Cardiol 52:1370-1378
18. Rochling FA 2001 Evaluation of abnormal liver tests. Clin Cornerstone 3:1-12
19. Snoeck V, Peters IR, Cox E 2006 The IgA system: a comparison of structure and function in different species. Vet Res 37:455-467
20. Monteiro RC, Van De Winkel JG 2003 IgA Fc receptors. Annu Rev Immunol 21:177-204
21. van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, van Hattum J, Kuiper J, van de Winkel JG 2000 FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 6:680-685
22. Gonzalez-Quintela A, Alende R, Gude F, Campos J, Rey J, Meijide LM, Fernandez-Merino C, Vidal C 2008 Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol 151:42-50
23. Rodriguez-Segade S, Camiña MF, Carnero A, Lorenzo MJ, Alban A, Quinteiro C, Lojo S 1996 High serum IgA concentrations in patients with diabetes mellitus: agewise distribution and relation to chronic complications. Clin Chem 42:1064-1067
24. Muscari A, Bozzoli C, Gerratana C, Zaca' F, Rovinetti C, Zauli D, La Placa M, Puddu P 1988 Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 74:179-186
25. Lopes-Virella MF, Virella G, Orchard TJ, Koskinen S, Evans RW, Becker DJ, Forrest KY 1999 Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Clin Immunol 90:165-172
26. Garrido-Sánchez L, Cardona F, García-Fuentes E, Rojo-Martínez G, Gómez-Zumaquero JM, Picón MJ, Soriguer F, Tinahones FJ 2008 Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus. Eur J Clin Invest 38:615-621
27. Friedman P, Hörkkö S, Steinberg D, Witztum JL, Dennis EA 2002 Correlation of antiphospholipid antibody recognition with the structure of synthetic oxidized phospholipids. Importance of Schiff base formation and aldol condensation. J Biol Chem 277: 7010-7020
28. Schenkein HA, Berry CR, Purkall D, Burmeister JA, Brooks CN, Tew JG 2001 Phosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins. Infect Immun 69:6612-6617
29. Chang MK, Bergmark C, Laurila A, Hörkkö S, Han KH, Friedman P, Dennis EA, Witztum JL 1999 Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidationspecific epitopes mediate macrophage recognition. Proc Natl Acad Sci USA 96:6353-6358
30. de Faire U, Su J, Hua X, Frostegård A, Halldin M, Hellenius M, Wikström M, Dahlbom I, Grönlund H, Frostegård J 2010 Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism. J Autoimmun 34:73-79
31. Wu R, Lemne C, de Faire U, Frostegård J 2001 Antibodies to lysophosphatidylcholine are decreased in borderline hypertension. Hypertension 37:154-159 (Pubitemid 32064254)
32. Su J, Georgiades A, Wu R, Thulin T, de Faire U, Frostegård J 2006 Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 188:160-166
33. Sjöberg BG, Su J, Dahlbom I, Grönlund H, Wikström M, Hedblad B, Berglund G, de Faire U, Frostegård J 2009 Low levels of IgM antibodies against phosphorylcholine-a potential risk marker for ischemic stroke in men. Atherosclerosis 203:528-532
34. Grönlund H, Hallmans G, Jansson JH, Boman K, Wikström M, de Faire U, Frostegård J 2009 Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden. Eur J Cardiovasc Prev Rehabil 16:382-386
35. Caligiuri G, Khallou-Laschet J, Vandaele M, Gaston AT, Delignat S, Mandet C, Kohler HV, Kaveri SV, Nicoletti A 2007 Phosphorylcholine-targeting immunization reduces atherosclerosis. J Am Coll Cardiol 50:540-546
36. Paschos P, Paletas K 2009 Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 13:9-19
37. Targher G, Marra F, Marchesini G 2008 Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 51:1947-1953
38. Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP 2005 Immune response toward lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54:987-993
39. Marchesini G, Moscatiello S, Di Domizio S, Forlani G 2008 Obesity-associated liver disease. J Clin Endocrinol Metab 93:S74-80
40. Delacroix DL, Reynaert M, Pauwels S, Geubel AP, Vaerman JP 1982 High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component. Dig Dis Sci 27: 333-340